Richen Europe S.r.l. is a Pharmaceutical Company founded in 2014 which operates on all European market.
EUROPEAN HELICOBACTER & MICROBIOTA STUDY GROUP 20222nd Richen Group Open Competition and Conference
The Richen group is launching its 2nd research competition, together with EHMSG.
Recent Products. SARS-COV-2 prevention and diagnosis, to limit the spread of the Covid-19 Virus: FFP2 mask, SARS-COV-2 rapid antigen test, SARS-COV-2 rapid serological test for IgM / IgG.
We produce only safe, highly accurate, pollution-free, non-toxicant, and easily use Medical Diagnostic and Instrumentation.
Since 2014ABOUT US
Focused on GastroenterologyMAIN PRODUCTS
We manufacture our own Medical Diagnostic and Medical Instruments focused on Gastroenterology field.
With the aim of contributing to the development of research on pathologies of the digestive tract, our Company is Gold Sponsor of the European group on the study of Helicobacter and of the microbiota.
Safe & Healthy Life
Last infos and International MeetingsNEWS & EVENTS
EUROPEAN HELICOBACTER & MICROBIOTA STUDY GROUP: CONFERENCE 2022
September 8 – 10, 2022 Glasgow, United Kingd...
2nd Richen Group Open Competition
2nd RICHEN GROUP OPEN COMPETITION for research in...
EUROPEAN HELICOBACTER & MICROBIOTA STUDY GROUP: VIRTUAL CONFERENCE 2021
September, 18th 2021 Online Conference...